Answers are grounded in this paper and cite their sources.
Aim The aim of this study was to evaluate overall survival (OS) in patients with early-stage glottic cancer treated with definitive radiation therapy (RT) and to assess local control (LC), disease-free survival (DFS), prognostic factors, and acute toxicity. Materials and methods This retrospective cohort study included 50 patients with early-stage glottic cancer treated with definitive RT between January 2018 and December 2023. Follow-up continued until December 2025. Twenty patients received intensity-modulated RT (IMRT), and 30 received three-dimensional conformal RT (3DCRT). The median prescribed dose was 66 Gy. OS was the primary endpoint. Secondary endpoints were LC, DFS, prognostic factors, and acute toxicity. Results The median follow-up was 32 months (range, 1-66 months). Complete response was reported in 48 patients (96%), partial response in one patient (2%), and disease progression in one patient (2%), who developed brain metastasis. Locoregional recurrence occurred in one patient, and distant metastasis occurred in one patient. In univariate analysis, anterior commissure (AC) involvement and tumor stage were significantly associated with DFS and OS. In multivariable analysis, AC involvement was also significantly associated with LC. Median OS was 34 months. No grade 2 or 3 radiation toxicity was reported. Conclusions Definitive RT was associated with a high complete-response rate, and few recurrences were reported in this cohort. The study describes outcomes among patients treated with 3DCRT or IMRT but does not establish the superiority of either technique.
No takes yet. Share an insight, caveat, or question.
Fatima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: